DE69626200D1 - Inhibierung von c. difficile-infektionen mit unverdaulichen oligosacchariden - Google Patents

Inhibierung von c. difficile-infektionen mit unverdaulichen oligosacchariden

Info

Publication number
DE69626200D1
DE69626200D1 DE69626200T DE69626200T DE69626200D1 DE 69626200 D1 DE69626200 D1 DE 69626200D1 DE 69626200 T DE69626200 T DE 69626200T DE 69626200 T DE69626200 T DE 69626200T DE 69626200 D1 DE69626200 D1 DE 69626200D1
Authority
DE
Germany
Prior art keywords
difficile
diarrhea
oligosaccharides
microflora
inhibit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69626200T
Other languages
English (en)
Other versions
DE69626200T2 (de
Inventor
Keith Allen Garleb
Brian Warren Wolf
Jonathan Allan Meulbroek
Keith Brian Wheeler
Shelia Martinson Campbell
Joseph Edward Walton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/417,411 external-priority patent/US5733579A/en
Priority claimed from US08/417,413 external-priority patent/US5688777A/en
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of DE69626200D1 publication Critical patent/DE69626200D1/de
Application granted granted Critical
Publication of DE69626200T2 publication Critical patent/DE69626200T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69626200T 1995-04-05 1996-04-04 Inhibierung von c. difficile-infektionen mit unverdaulichen oligosacchariden Expired - Lifetime DE69626200T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/417,411 US5733579A (en) 1995-04-05 1995-04-05 Oral rehydration solution containing indigestible oligosaccharides
US08/417,413 US5688777A (en) 1995-04-05 1995-04-05 Inhibition of C. difficile infections by indigestible oligosaccharides
PCT/US1996/004665 WO1996031219A1 (en) 1995-04-05 1996-04-04 Inhibition of c. difficile infections by indigestible oligosaccharides

Publications (2)

Publication Number Publication Date
DE69626200D1 true DE69626200D1 (de) 2003-03-20
DE69626200T2 DE69626200T2 (de) 2003-12-18

Family

ID=27023728

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69626200T Expired - Lifetime DE69626200T2 (de) 1995-04-05 1996-04-04 Inhibierung von c. difficile-infektionen mit unverdaulichen oligosacchariden

Country Status (14)

Country Link
EP (1) EP0820292B1 (de)
JP (1) JPH11503168A (de)
AT (1) ATE232389T1 (de)
AU (1) AU704004B2 (de)
CA (1) CA2217157C (de)
DE (1) DE69626200T2 (de)
DK (1) DK0820292T3 (de)
ES (1) ES2194988T3 (de)
HK (1) HK1008492A1 (de)
MX (1) MX9707631A (de)
NO (1) NO313685B1 (de)
NZ (1) NZ306712A (de)
PT (1) PT820292E (de)
WO (1) WO1996031219A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1166800B1 (de) * 2000-06-28 2006-03-22 B.S.D. BIO SCIENCE DEVELOPMENT SNC Di OMINI C. & ZUCCARI G. Pharmazeutische Zusammensetzungen von Antibiotika und Fruktan-Gemische
EP1243273A1 (de) † 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Zubereitung enthaltend einen praebiotischen Stoff für die Behandlung von Entzündungen und abnormale Aktivierung von nicht-spezifischen immunologischen Parametern
US20110245171A1 (en) * 2004-09-30 2011-10-06 Hardin James A Rehydration compositions comprising epidermal growth factor (egf)
US20100063002A1 (en) * 2007-03-13 2010-03-11 Bernd Stahl Method of improving skills with a composition comprising non-digestible saccharide
CN109069521A (zh) * 2016-03-14 2018-12-21 物产食品科技股份有限公司 粪杆菌属细菌增殖剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902674A (en) * 1987-10-13 1990-02-20 Coors Biotech, Inc. Method for inhibiting the growth of salmonella
AU634746B2 (en) * 1989-02-07 1993-03-04 Dimminaco Ag/Sa/Ltd. Effervescent composition for oral rehydration
US5397786A (en) * 1993-01-08 1995-03-14 Simone; Charles B. Rehydration drink

Also Published As

Publication number Publication date
ES2194988T3 (es) 2003-12-01
CA2217157C (en) 2002-07-30
AU704004B2 (en) 1999-04-01
PT820292E (pt) 2003-06-30
WO1996031219A1 (en) 1996-10-10
DK0820292T3 (da) 2003-05-19
JPH11503168A (ja) 1999-03-23
NO313685B1 (no) 2002-11-18
ATE232389T1 (de) 2003-02-15
NO974490D0 (no) 1997-09-29
HK1008492A1 (en) 1999-05-14
MX9707631A (es) 1998-04-30
EP0820292B1 (de) 2003-02-12
AU5534296A (en) 1996-10-23
NZ306712A (en) 1999-10-28
CA2217157A1 (en) 1996-10-10
NO974490L (no) 1997-09-29
EP0820292A1 (de) 1998-01-28
DE69626200T2 (de) 2003-12-18

Similar Documents

Publication Publication Date Title
US3940478A (en) Proteolytic enzymes as adjuncts to antibiotic prophylaxis of contaminated wounds
ES2091290T3 (es) Tratamiento para la diarrea por clostridium difficile y colitis pseudomembranosa.
GEP20012415B (en) THF-Containing Sulfonamide Inhibitors of Aspartyl Protease
ATE242216T1 (de) Tricyclische verbindungen als inhibitoren von farnesyl protein transferase
TR199700726T1 (xx) Farnezil transferaz �nleyiciler ve m�stahzarlar�.
ES2083977T3 (es) Composiciones biocidas.
AU5669198A (en) Cyclosporin derivative, its preparation and pharmaceutical compositions containing same
ATE232389T1 (de) Inhibierung von c. difficile-infektionen mit unverdaulichen oligosacchariden
MX9708611A (es) Compuestos de dialquiltiacumicina.
ES479636A1 (es) Procedimiento para la obtencion de un antibiotico de efecto sinergistico.
NO20001758L (no) FremgangsmÕter og blandinger for behandling av leddgikt
PT666755E (pt) Inibicao da infeccao pelo vih
DE3260277D1 (en) Peptide antibiotic, component b, process for its preparation and its use in medicines
NO944246D0 (no) Halogenerte 4'-metoksyacetofenoner som mikrobicider og preserveringsmidler
DE3377798D1 (de) Nargenicin c1
JPS54101231A (en) Dynmic type rom
ES546915A0 (es) Procedimiento para preparar nuevos antibioticos policiclicos por fermentacion de una cepa de actinomadura melliaura.
BG102014A (en) Carbapenem esters

Legal Events

Date Code Title Description
8364 No opposition during term of opposition